LEC 2.1 (ACUTE CARE) Flashcards

(83 cards)

1
Q

PAGE 3

A

-

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

PAGE 4

A

-

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Medical conditions associated with falls:

A

neurologic, orthopedic, cognitive, postural/orthostatic
hypotension

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Either allergic to the natural rubber in latex, or the chemicals used to
produce latex

Includes gloves, stethoscopes, cuffs, airway and IV tubing, electrodes;
etc.

A

Latex Allergy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

State of being unhealthy for a particular disease or situation

A

Morbidity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

number of deaths that occur in a population.

A

mortality

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Page 6-11

A

-

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

It is a place of intensive medical-surgical care for patients who require
continuous monitoring, usually in conjunction with other therapies or
medical interventions such as vasoactive medications, sedation, circulatory assist devices, and mechanical ventilation

May be PICU, CCU, SICU depending on patient distributio

A

Intensive Care Unit

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Page 14-15

A

*ICU Delirium or syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Increased with MV, emergency surgery, polytrauma, organ failure uM
metabolic acidosis, coma, dementia, or advanced age

A

ICU delirium or syndrom

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

A.) Blood Urea Nitrogen (BUN), Plasma creatinine reduced in patients with HE
levels, and urine output
B.) Creatine kinase MB subunit (CK-MB)
C.) B-type natriueretic peptide (BNP)
D.) Hemoglobin and Hematrocrit levels

  1. Assess biomarkers of heart failure
  2. Assess renal function, reduced in HF
  3. Assess the oxygen carrying capacity within the system
  4. Isoenzyme, released into blood and elevates with acute MI
A
  1. C
  2. A
  3. D
  4. B
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Other possible risk factors

A

include hypoxemia, use of certain benzodiazepine and narcotic
medications, infection, immobilization, and pain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

A.) Troponin I
B.) C-reactive protein
C.) Electrolyte asessment

  1. most frequently used to assess MI
  2. Appropriate levels of K, Ca, Mg allow fornormal electrial conduction through the heart
  3. Measures amount of protein blood
  4. Isotype in myocardium
    5.Signals acute inflammation
  5. 100% cardiac specific
  6. determine risk of heart disease –> high sensitivity C-reactice protein assay is available
A
  1. A
  2. C
  3. B
  4. A
  5. B
  6. A
  7. B
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

SYSTEMIC EFFECTS OF PROLONGED BED REST

CARDIAC

A

° Increased heart rate at rest and with submaximal exercise
° Decreased stroke volume, VO2 Max, Left ventricular volume, and
cardiac output
° Myocardial thinning
° Orthostatic hypotension

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

RESPIRATORY

A

° Decreased lung volumes and capacities, (FRC, FVC, FEVI)
° Decreased mucocilliary clearance
° Increased risk of pneumonia, atelectasis, and pulmonary embolism
° Decreased arterial oxygen saturation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

HEMATOLOGIC

A

° Decreased total blood volume, red blood cell mass, and plasma
volume
° Increased hematocrit
° Venous stasis, hypercoagulability, blood vessel damage

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

GASTROINTESTINAL

A

° Decreased appetite, fluid intake, bowel motility, and gastric
bicarbonate secretion
o GERD
° Difficulty swallowing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

GENITOURINARY

A

° Increased mineral excretion, kidney stones, difficulty voiding, and
urinary retention
°Increased risk of urinary tract infection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

ENDOCRINE

A

° Altered temperature and sweating responses, circadian rhythm,
regulation of hormones, increased cortisol and glucose intolerancg
° Decreased overall metabolism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

MUSCULOSKELETAL

A

° Increased muscle weakness (especially antigravity muscles),
atrophy, decreased muscle endurance, risk of contracture,
weakened myotendinous junction
° Disuse osteoporosis
° Degeneration of cartilage, synovial atrophy, and ankylosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

NEUROLOGIC

A

° Sensory and social deprivation
° Decreased dopamine, noradrenaline, and serotonin levels
° Depression, restlessness, insomnia
° Decreased balance, coordination, and visual acuity
° Increased risk of compression neuropathy
° Reduced pain threshold

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

INTEGUMENTARY

A

° Increased risk of pressure injury formation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

IMMUNE

A

° Increased risk of reactivation of latent viruses
° Reduced immune response and immunity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

PSYCHOLOGICAL

A

° Impaired self worth and self esteem
° Increased risk of delirium, depression, and post-traumatic stress
syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
BODY COMPOSITION
° Increased sodium, potassium, calcium, phosphorus, and nitrogen loss ° Increased body fat and decreased lean body mass ° Fluid shift from legs to abdomen/thorax/head, diuresis
24
-Patients may be confined to the hospital setting with an infectious disease process or may develop one caused by the hospital environment. -Therefore a basic understanding of these infectious disease processes is useful in designing, implementing, and modifying physical therapy treatment programs.
INFECTIOUS DISEASES
25
° Highly specific protein that is manufactured in response to antigens and defends against subsequent infection
ANTIBODY
26
° Agent that is capable of producing antibodies when introduced into a body of a susceptible person
ANTIGEN
27
The ability of an infective organism to be transmitted from persor | person, either directly or indirectly
COMMUNICABLE
28
° Localized or systemic condition resulting from an adverse reaction to the presence of an infectious agents(s) or its toxin(s); there must be no evidence that the infection was present or incubating at the time of admission to the acute care setting
HEALTH CARE ASSOCIATED INFECTION
29
An immune system that is incapable of a normal response pathogenic organisms and tissue damage
IMMUNOCOMPROMISED
30
° Decreased or compromised ability to respond to antigenic stimuli by appropriate cellular immunity reaction
IMMUNODEFICIENCY
31
° The prevention or diminution of the immune response, as by drugs or radiation
IMMUNOSUPPRESION
32
° Infection acquired in the hospital setting; note that this has b: replaced by the term HAI (see above)
NOSOCOMIAL INFECTION
33
o An infectious process that develops in immunosuppressed individuals
OPPORTUNISTIC (Opportunistic infections normally do not develop in individuals with intact immune systems.)
34
° A disease or condition that does not produce clinical symptoms, or the period before the appearance of disease specific symptoms
SUBCLINICAL INFECTION
35
PAGE 32-36
-
36
Airborne droplet nuclei can stay for ___
More than an hr travel >10 ft d/t small size (<5micrometers)
37
A single patient room equipped c special air hand and ventilation capacity (e.g. negative pressure)
Airborne Infection Isolation Room (AIIR)
38
Mask/faceshield required when___
Large particle >5micromter if droplet transmiision <=3 ft is likely spatial seperation of >= 3 ft
39
Due to inappropriate antibiotic use in healthcare institutions and hospitals
ANTIBIOTIC RESISTANT INFECTIONS
40
At least one agent in three or more antimicrobial categories
MULTIDRUG-RESISTANT (MDR)
41
At least one agent in all but two or fewer categories
EXTENSIVELY DRUG-RESISTANT (XDR)
42
Nonsusceptibility to all agents in all antimicrobial categories’
PANDRUG-RESISTANT (PDR)
43
Antibiotic Resistant Infections
-Methicilin Resistant Staphylococcus (MRSA) -Vancomycin Resistant Enterococcus (VRE) -Multi-drug resistant Acinetobacter baumannii (MDRAB)
44
general indication: hypoxemia Indications: severe trauma, shock, acute myocardial infarction, surgery, carbon monoxide/cyanide poisoning
OXYGEN THERAPY - Increase O2 levels in the blood and alveoli to improve oxygenation
45
PAGE 39-40
-
46
HYPOXEMIA
° SaO2 <90% ° Arterial blood O02 partial pressure is <60 mmHG
46
VARIABLE OXYGEN DELIBERY FOR SBA
NASAL CANULA OPEN FACE TENT CLOSED FACE MASK TRANSTRACHEAL OXYGEN CATHETER TRACHEOSTOMY MASK/COLLAR PARTIAL NONREBREATHER MASK NONREBREATHER MASK
47
A) Tracheostomy mask/collar B) Parial non-rebreather mask C) Non-rebreather mask 1. Provides a high Fi02 to the patient while conserving the O2 supply 2. Q2 available via a face mask in a variable-performance system 3. One way valves control inflow of supplemental O2 and outflow of exhaled air so that the patient is only breathing the supplied 02 4. Provides supplemental, humidified O2 or air at a tracheostomy site 5. Fio2 - 28 to 100% 6. Fio2 - 40 to 60% 7. Fio2 - 60 to 80% 8. Mix of supplemental 02 and RA 9. Two-way valves in the mask allow for RA inhalation in addition supplemental O02. 10. Provides the patient with the highest concentration of supplemental
1. B 2. C 3. C 4. A 5. A 6. B 7. C 8. B 9. B 10. C
47
A) Nasal Cannula B) Open Face Tent C) Closed Face Mask D) Transtracheal oxygen catheter 1. Delivers supplemental O2 mixed with RA 2. Fio2 - 24 to 44% 3. Can also be used for nebulized medications 4. Delivers supplemental O2 mixed with RA (21%), usually I-6 lpm 5. Mask capacity is limited but does allow for the collection of O2 about the nose and mouth 6. Fio2 - 30 to 55% 7. Used for long-term O2 therapy 8. Provides humidified, supplemental 02 mixed with RA 9. Fio2 - 40 to 60% 10. Indicated when there are complications with or suboptimal nasal cannula use, nocturnal hypoxemia despite nasal cannula
1. C 2. A 3. B 4. A 5. C 6. B 7. D 8. B 9. C 10. D
48
PAGE 50
-
48
FIXED PERFORMANCE OXYGEN DELIVERY A) Air Entrapment Mask B) BiPAP 1. Fio2 - 24, to 50% 2. Often used in the hospital or home setting for the managemeR 3. Provides a specific concentration of supplemental O2 using color- coded diluter pieces to ensure accurate FiO2 delivery 4. May be used to avoid intubation and mechanical ventilation 5. Pressure-supported, noninvasive ventilation that provides positive inspiratory and end-expiratory pressure 6. Fio2 21 to 100%
1. A 2. B 3. A 4. B 5. B 6. B Both deliver air pressure when you breathe in and breathe out. But a BiPAP delivers higher air pressure when you breathe in. The CPAP, on the other hand, delivers the same amount of pressure at all times. So the BiPAP makes it easier to breathe out than the CPAP.
48
PAGE 52
-
49
Non-Invasive Medical Monitoring A) BP cuff B) Telemetry C) Pulse oximeter 1.) Continuous monitoring of heart rate and rhythm and respiratory 2.) A noninvasive, transcutaneous method of monitoring the percentg of hemoglobin saturated with O2 in arterial blood 3.) Measures arterial BP
BCA
50
Invasive Medical Monitoring A) Arterial Line B) Central Venous Catheter 1.) Indicated for a patient with significant fluid volume deficit and is used as a guide to overall fluid balance 2.) Measurement of CVP is a direct reflection of right heart function 3.) Direct and continuous monitoring of systolic, diastolic, and MAP; source for repeated arterial blood gas 4.) Also provides vascular access for parenteral nutrition, large fluid volumes, or noxious medications
BBAB
51
NORMAL VALUES SBP/DBP & MAP
Systolic: 90-140 mmHg Diastolic: 60-80 mmHg MAP: 70-100 mmHg
52
CVP Normal value:
2-5 mmHg or 3-8 cm water (H20)
53
PAGE 56-57
-
54
° Provides access for long-term hemodialysis
AV fistula/graft
55
-Removes and prevents the reentry of air or fluid from the pleural or mediastinal space and provides negative intrapleural pressure -Used to treat pneumothorax, hemothorax, pleural effusion
Chest Tube
56
For feeding, gastric decompression and keeping the stomach em after surgery
Nasogastric Tube
57
PAGE 59-61
-
58
MEDICAL SURGICAL MANAGEMENT DEVICE
--------------------------------------------
59
Delivers aerosolized water or medications to the respiratory tract, lungs, throat, or nose
NEBULIZER
60
Provides long-term access for nourishment to patients who are unable to tolerate food by mouth or have a nasoenteral obstruction, or for a patient with confusion/ agitation at risk for nasoents tube dislodgement
PERCUTANEOUS ENDOSCOPIC GASTROTOMY/JEJUNOSTOMY
61
PAGE 63-64
-
61
° Provides temporary access for delivery of medications, fluids, electrolytes, nutrients, or blood product transfusions ° It cannot be used to draw blood
PERIPHERAL IV LINE
62
° Provides IV access for administration of total parenteral nutrition (TPN), medications, fluid, blood products, or chemotherapy. ° Generally placed for midterm access (weeks to months)
PERIPHERALLY INSERTED CENTRAL CATHETER
63
PAGE 66-67
63
° Provides intermittent pressure to the lower extremities via gradual and sequential inflation and deflation of the air-filled sleeves ° Promotes venous return and prevents deep vein thrombosis (DVT) and venous thromboembolism (VTE) secondary to prolonged or postoperative bed rest or inactivity
SEQUENTIAL COMPRESSION DEVICES
64
PAGE 69
-
65
° Surgically placed catheter to drain the bladder temporarily or permanently after some bladder or gynecologic surgeries in cases of urinary retention (possibly caused by an obstruction tumor, stricture, periurethral abscess) or a severe voiding dysfunction °May be used for SCI patients
Suprapubic catheter
66
PAGE 71
-
67
° Removes excess air, blood, or fluid (serum, lymph, bile, pus, or intestinal secretions) from a surgical site that would otherwise collect internally ° To control ecchymosis and to prevent deep wound infection
SURGICAL DRAIN (PENROSE, JACKSON PRATT, HEMOVAC)
68
° Noninvasively collects urine via a sheath placed over the penis ° Does not assist with drainage of urine from the bladder
TEXAS CATHETER
69
PAGE 73-74
-
70
° Used for long-term (months to years) chemotherapy, hemodialysis, TPN, or other intermittent infusion therapy
VASCULAR ACCESS PORT
71
A catheter inserted through urethra in both M and W to drain and collect urine TEMPORARILY (<3 WKS) Used for urinary incontinence/retention, to assist postoperative bladder drainage, when accurate measurement in urine output is necessary, to prevent contamination in patients With stage 2,3,4 pressure injury on the buttocks/perineum
URINARY CATHETER
72
PAGE 76
-
73
Drains excess CSF from the ventricles into the abdominal cavity/peritoneum (VP) or right atrium of the heart (VA)
VENTRICULOPERITONEAL SHUNT
74
Clears secretions from the oral cavity or the oropharynx
Yankauer suction
75
PAGE 78-88
------